BA
DRIOW

Bard Associates’s DarioHealth Corp. Warrant DRIOW Stock Holding History

Bard Associates’s Portfolio DRIOW Stock Details DRIOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-61,989
Closed -$1K – 165
2019
Q4 		$1K Sell
61,989
-1,900
-3% -$43 ﹤0.01% 164
2019
Q3 		$3K Sell
63,889
-1,500
-2% -$65 ﹤0.01% 166
2019
Q2 		$1K Hold
65,389
– – ﹤0.01% 162
2019
Q1 		$1K Hold
65,389
– – ﹤0.01% 167
2018
Q4 		$1K Sell
65,389
-1,000
-2% -$117 ﹤0.01% 170
2018
Q3 		$9K Buy
+66,389
New +$12.8K ﹤0.01% 168
2018
Q2 		– Hold
0
– – – 173
2018
Q1 		– Hold
0
– – – 171
2017
Q4 		– Hold
0
– – – 171
2017
Q3 		– Hold
0
– – – 173
2017
Q2 		– Hold
0
– – – 181
2017
Q1 		– Hold
0
– – – 177
2016
Q4 		– Hold
0
– – – 169
2016
Q3 		– Hold
0
– – – 167

Other funds holding DRIOW

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bard Associates's DRIOW Position: Q1 2020 in Review

Bard Associates sold out of DarioHealth Corp. Warrant (DRIOW) in Q1 2020, closing a stake of 61,989 shares — an estimated $1K sold.

Bard Associates first reported a position in DRIOW in Q3 2018 and held it in 6 quarters. The position peaked at $9K in Q3 2018. 3 funds tracked by Wall St. Rank hold DRIOW as of Q1 2020.

  • Bard Associates reported no remaining DarioHealth Corp. Warrant position as of Q1 2020 after selling out during the quarter.
  • Bard Associates sold 61,989 DarioHealth Corp. Warrant shares in Q1 2020, an estimated $1K.
  • Bard Associates first reported a position in DarioHealth Corp. Warrant in Q3 2018 and held it in 6 quarters.
  • Bard Associates's DarioHealth Corp. Warrant position peaked at $9K in Q3 2018.
  • 3 funds tracked by Wall St. Rank held DarioHealth Corp. Warrant as of Q1 2020.

Based on Bard Associates's 13F filing for Q1 2020, filed 13 May 2020.